Publications by authors named "Pavlos Msaouel"

90Publications

Systemic Therapies for the Management of Non-Clear Cell Renal Cell Carcinoma: What Works, What Doesn't, and What the Future Holds.

Authors:
Panagiotis Zoumpourlis Giannicola Genovese Nizar M Tannir Pavlos Msaouel

Clin Genitourin Cancer 2020 Dec 2. Epub 2020 Dec 2.

Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX; Center for Precision Environmental Health, Baylor College of Medicine, Houston, TX. Electronic address:

View Article and Find Full Text PDF
December 2020

TAM kinase inhibition and immune checkpoint blockade- a winning combination in cancer treatment?

Authors:
Pavlos Msaouel Giannicola Genovese Jianjun Gao Suvajit Sen Nizar M Tannir

Expert Opin Ther Targets 2020 Dec 31:1-11. Epub 2020 Dec 31.

Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center , Houston, TX, USA.

View Article and Find Full Text PDF
December 2020

Molecular profiling of metastatic bladder cancer early-phase clinical trial participants predicts patient outcomes.

Authors:
Omar Alhalabi Andrew W Hahn Pavlos Msaouel Alexander Y Andreev-Drakhlin Funda Meric-Bernstam Aung Naing Sarina Piha-Paul Janku Filip Shubham Pant Timothy A Yap David S Hong Siqing Fu Daniel Karp Erick Campbell Hung Le Matthew T Campbell Amishi Y Shah Nizar M Tannir Arlene O Siefker-Radtke Jianjun Gao Jason Roszik Vivek Subbiah

Mol Cancer Res 2020 Dec 15. Epub 2020 Dec 15.

Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center

View Article and Find Full Text PDF
December 2020

Validation of prognostic scoring systems for patients with metastatic renal cell carcinoma enrolled in phase I clinical trials.

Authors:
Andrew W Hahn Omar Alhalabi Pavlos Msaouel Funda Meric-Bernstam Aung Naing Eric Jonasch Sarina Piha-Paul David Hong Shubham Pant Timothy Yap Erick Campbell Hung Le Nizar M Tannir Jason Roszik Vivek Subbiah

ESMO Open 2020 11;5(6)

Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

View Article and Find Full Text PDF
November 2020

Outcomes of patients with metastatic renal cell carcinoma with sarcomatoid dedifferentiation to immune checkpoint inhibitors.

Authors:
Jad Chahoud Pavlos Msaouel Jeremy A Ross Barrett Z McCormick Tharakeswara K Bathala Jianjun Gao Robert Horn Lianchun Xiao Kanishka Sircar Matthew T Campbell Amishi Y Shah Sangeeta Goswami Amado J Zurita Eric Jonasch Surena F Matin Christopher G Wood Jose A Karam Padmanee Sharma Nizar M Tannir

Urol Oncol 2020 Nov 10. Epub 2020 Nov 10.

The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article and Find Full Text PDF
November 2020

Loss of ARID1A Promotes Epithelial-Mesenchymal Transition and Sensitizes Pancreatic Tumors to Proteotoxic Stress.

Authors:
Hideo Tomihara Federica Carbone Luigi Perelli Justin K Huang Melinda Soeung Johnathon L Rose Frederick S Robinson Yonathan Lissanu Deribe Ningping Feng Mitsunobu Takeda Akira Inoue Edoardo Del Poggetto Angela K Deem Anirban Maitra Pavlos Msaouel Nizar M Tannir Giulio F Draetta Andrea Viale Timothy P Heffernan Christopher A Bristow Alessandro Carugo Giannicola Genovese

Cancer Res 2021 Jan 6;81(2):332-343. Epub 2020 Nov 6.

Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article and Find Full Text PDF
January 2021

Expression of IGF-IEc Isoform in Renal Cell Carcinoma Tissues.

Authors:
Fani Michalopoulou Constantina Petraki Anastassios Philippou Antonis Analitis Pavlos Msaouel Michael Koutsilieris

Anticancer Res 2020 Nov;40(11):6213-6219

Department of Physiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece

View Article and Find Full Text PDF
November 2020

Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma.

Authors:
Jianjun Gao Neema Navai Omar Alhalabi Arlene Siefker-Radtke Matthew T Campbell Rebecca Slack Tidwell Charles C Guo Ashish M Kamat Surena F Matin John C Araujo Amishi Y Shah Pavlos Msaouel Paul Corn Jianbo Wang John N Papadopoulos Shalini S Yadav Jorge M Blando Fei Duan Sreyashi Basu Wenbin Liu Yu Shen Yuwei Zhang Marc Daniel Macaluso Ying Wang Jianfeng Chen Jianhua Zhang Andrew Futreal Colin Dinney James P Allison Sangeeta Goswami Padmanee Sharma

Nat Med 2020 12 12;26(12):1845-1851. Epub 2020 Oct 12.

Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article and Find Full Text PDF
December 2020

Fear of Cancer Recurrence in Patients With Localized Renal Cell Carcinoma.

Authors:
Cristiane Decat Bergerot Dena Battle Errol J Philip Paulo Gustavo Bergerot Pavlos Msaouel Allan 'Ben' Smith Adeola Esther Bamgboje Brian Shuch Ithaar H Derweesh Eric Jonasch Adam P Stern Sumanta K Pal Michael Staehler

JCO Oncol Pract 2020 Nov 18;16(11):e1264-e1271. Epub 2020 Sep 18.

Department of Urology, Ludwig-Maximilians University, Munich, Germany.

View Article and Find Full Text PDF
November 2020

Molecular hallmarks of renal medullary carcinoma: more to c-MYC than meets the eye.

Authors:
Pavlos Msaouel Cheryl L Walker Giannicola Genovese Nizar M Tannir

Mol Cell Oncol 2020 23;7(5):1777060. Epub 2020 Jun 23.

Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article and Find Full Text PDF
June 2020

Causal Diagram Techniques for Urologic Oncology Research.

Authors:
Daniel D Shapiro Pavlos Msaouel

Clin Genitourin Cancer 2020 Aug 13. Epub 2020 Aug 13.

Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article and Find Full Text PDF
August 2020

Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma.

Authors:
Pavlos Msaouel Gabriel G Malouf Xiaoping Su Hui Yao Durga N Tripathi Melinda Soeung Jianjun Gao Priya Rao Cristian Coarfa Chad J Creighton Jean-Philippe Bertocchio Selvi Kunnimalaiyaan Asha S Multani Jorge Blando Rong He Daniel D Shapiro Luigi Perelli Sanjana Srinivasan Federica Carbone Patrick G Pilié Menuka Karki Riyad N H Seervai Bujamin H Vokshi Dolores Lopez-Terrada Emily H Cheng Ximing Tang Wei Lu Ignacio I Wistuba Timothy C Thompson Irwin Davidson Virginia Giuliani Katharina Schlacher Alessandro Carugo Timothy P Heffernan Padmanee Sharma Jose A Karam Christopher G Wood Cheryl L Walker Giannicola Genovese Nizar M Tannir

Cancer Cell 2020 05 30;37(5):720-734.e13. Epub 2020 Apr 30.

Department of Genitourinary Medical Oncology, Unit 1374, The University of Texas MD Anderson Cancer Center, 1155 Pressler Street, Houston, TX 77030-3721, USA. Electronic address:

View Article and Find Full Text PDF
May 2020

A phase I-II design based on periodic and continuous monitoring of disease status and the times to toxicity and death.

Authors:
Juhee Lee Peter F Thall Pavlos Msaouel

Stat Med 2020 Jul 7;39(15):2035-2050. Epub 2020 Apr 7.

Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article and Find Full Text PDF
July 2020

Cancer Genetics and Therapeutic Opportunities in Urologic Practice.

Authors:
Jacob J Adashek Alex Leonard Jason Roszik Arjun K Menta Giannicola Genovese Vivek Subbiah Pavlos Msaouel

Cancers (Basel) 2020 Mar 18;12(3). Epub 2020 Mar 18.

Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article and Find Full Text PDF
March 2020

Nivolumab for the Treatment of Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma (nccRCC): A Single-Institutional Experience and Literature Meta-Analysis.

Authors:
Jad Chahoud Pavlos Msaouel Matthew T Campbell Tharakeswara Bathala Lianchun Xiao Jianjun Gao Amado J Zurita Amishi Yogesh Shah Eric Jonasch Padmanee Sharma Nizar M Tannir

Oncologist 2020 03 9;25(3):252-258. Epub 2019 Sep 9.

The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article and Find Full Text PDF
March 2020

Expression of Kisspeptin (KISS1) and its Receptor GPR54 (KISS1R) in Prostate Cancer.

Authors:
Ioannis Xoxakos Constantina Petraki Pavlos Msaouel Athanasios Armakolas Alkiviadis Grigorakis Stefanos Stefanakis Michael Koutsilieris

Anticancer Res 2020 02;40(2):709-718

Department of Physiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece

View Article and Find Full Text PDF
February 2020

Recent advancements in the treatment of metastatic clear cell renal cell carcinoma: A review of the evidence using second-generation p-values.

Authors:
Jacob J Adashek Giannicola Genovese Nizar M Tannir Pavlos Msaouel

Cancer Treat Res Commun 2020 Jan 3;23:100166. Epub 2020 Jan 3.

Department of Genitourinary Medical Oncology, Unit 1374, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, 1155 Pressler St, Houston, TX 77030-3721, USA. Electronic address:

View Article and Find Full Text PDF
January 2020

Discrepancy in calculated and measured glomerular filtration rates in patients treated with PARP inhibitors.

Authors:
Graziela Zibetti Dal Molin Shannon Neville Westin Pavlos Msaouel Larissa M Gomes Andrea Dickens Robert L Coleman

Int J Gynecol Cancer 2020 01 1;30(1):89-93. Epub 2019 Dec 1.

Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

View Article and Find Full Text PDF
January 2020

Nivolumab for the Treatment of Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma (nccRCC): A Single-Institutional Experience and Literature Meta-Analysis.

Authors:
Jad Chahoud Pavlos Msaouel Matthew T Campbell Tharakeswara Bathala Lianchun Xiao Jianjun Gao Amado J Zurita Amishi Yogesh Shah Eric Jonasch Padmanee Sharma Nizar M Tannir

Oncologist 2019 Sep 9. Epub 2019 Sep 9.

The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

View Article and Find Full Text PDF
September 2019

Temsirolimus versus Pazopanib (TemPa) in Patients with Advanced Clear-cell Renal Cell Carcinoma and Poor-risk Features: A Randomized Phase II Trial.

Authors:
Nizar M Tannir Pavlos Msaouel Jeremy A Ross Catherine E Devine Anuradha Chandramohan Graciela M Nogueras Gonzalez Xuemei Wang Jennifer Wang Paul G Corn Zita D Lim Lisa Pruitt Jose A Karam Christopher G Wood Amado J Zurita

Eur Urol Oncol 2020 10 2;3(5):687-694. Epub 2019 Jul 2.

Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article and Find Full Text PDF
October 2020